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Abstract
Background: Chronic inguinodynia (groin pain) is a common complication following open inguinal hernia repair or a
Pfannenstiel incision but may also be experienced after other types of (groin) surgery. If conservative treatments are to
no avail, tailored remedial surgery, including a neurectomy and/or a (partial) meshectomy, may be considered.
Retrospective studies in patients with chronic inguinodynia suggested that spinal anaesthesia is superior compared to
general anaesthesia in terms of pain relief following remedial operations. This randomised controlled trial is designed
to study the effect of type of anaesthesia (spinal or general) on pain relief following remedial surgery for inguinodynia.
Methods: A total of 190 adult patients who suffer from unacceptable chronic (more than 3 months) inguinodynia, as
subjectively judged by the patients themselves, are included. Only patients scheduled to undergo a neurectomy and/
or a meshectomy by an open approach are considered for inclusion and randomised to spinal or general anaesthesia.
Patients are excluded if pain is attributable to abdominal causes or if any contraindications for either type of
anaesthesia are present. Primary outcome is effect of type of anaesthesia on pain relief. Secondary outcomes include
patient satisfaction, quality of life, use of analgesics and (in)direct medical costs. Patient follow-up period is one year.
Discussion: The first patient was included in January 2016. The expected trial deadline is December 2019. Potential
effects are deemed related to the entire setting of type of anaesthesia. Since any setting is multifactorial, all of these
factors may influence the outcome measures.
This is the first large randomised controlled trial comparing the two most frequently used anaesthetic techniques in
remedial surgery for groin pain. There is a definite need for evidence-based strategies to optimise results of these types
of surgery. Besides pain relief, other important patient-related outcome measures are assessed to include patient’s
perspectives on outcome.
Trial registration: The protocol (protocol number NL54115.015.15) is approved by the Medical Ethics Committee
of Máxima Medical Centre, Veldhoven, The Netherlands. The study protocol was registered at www.trialregister.nl
(NTR registration number: 5586) on 15 January 2016.
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Chronic postoperative groin pain (inguinodynia) is defined
as pain beyond 3 months after inguinal surgery. In the ma-
jority of patients, inguinodynia develops following open
inguinal hernia repair (66%; Zwaans WA, van Kuijk SM,
le Mair LH, van Kleef M, Scheltinga MR, Roumen RM –
unpublished observations). One third of patients with
chronic postherniorrhaphy pain experience impairment of
daily activities [1, 2]. This pain is either neuropathic (47–
70%), nociceptive (26%) or a combination [3]. Inguinody-
nia may also be found after other types of groin surgery
[4–7]. Concise history taking and an extensive physical
examination provide the cornerstones for diagnosing
inguinodynia. A diagnostic local nerve block may confirm
the diagnosis [8, 9]. Interestingly, one of three patients
benefits from these injections on the long term [10].
When these minimally invasive regimens fail, surgical op-
tions may be considered. Removal of the inguinal nerves,
funiculolysis, and/or removal of the mesh may all be ef-
fective [7, 11–14, 17]. Furthermore, the post-Pfannenstiel
pain syndrome, which often is neuropathic in origin, also
responds well to an inguinal neurectomy [4].
The SolviMáx Centre of Excellence is a third-line referral
centre for abdominal wall and groin pain. Experience with
a spectrum of surgical procedures for inguinodynia is grow-
ing. One retrospective study in patients with inguinodynia
suggested that spinal anaesthesia is associated with a super-
ior outcome in terms of pain relief when compared to
general anaesthesia [15]. A more robust trial is required to
confirm these preliminary findings. The objective of the
present paper is to present a randomised controlled trial
that is designed to investigate the effect of type of anaesthe-
sia on long-term pain relief in patients who are surgically
treated for chronic inguinodynia.
Methods
Trial design
This monocenter, nonblinded, randomised controlled trial
is performed in the SolviMáx Centre of Excellence for
Abdominal Wall and Groin Pain. SolviMáx is a subdivision
of the Surgical Department of Máxima Medical Center
(MMC), a teaching hospital situated in the southern part of
The Netherlands serving a population of approximately
200,000 inhabitants. The study aims at investigating a po-
tential difference in pain relief following remedial surgery
that is performed in two different settings, spinal anaesthe-
sia versus general anaesthesia. The present trial is not
considered a drug study as other variables associated with
type of anaesthesia are not under control of the investiga-
tors. The present trial follows guidelines of the declaration
of Helsinki (version 19 October 2013). The protocol (proto-
col number NL54115.015.15) is approved by the Medical
Ethics Committee of Máxima Medical Centre, Veldhoven,
the Netherlands. The study protocol (version 1) is registered
at www.trialregister.nl (NTR registration number: 5586).
The present paper is written according to the Standard
Protocol Items: Recommendations for Interventional Trials
(SPIRIT) 2013 Statement for reporting a clinical trial
protocol [16]. The SPIRIT Checklist is provided as
Additional file 1.
Participants
Patient enrolment started in January 2016. Chronic
inguinodynia that is unacceptable as subjectively judged
by patients themselves is a prerequisite for inclusion.
Only patients scheduled to undergo remedial surgery
including a neurectomy and/or a meshectomy (if pa-
tients have mesh) by an open approach are considered
for inclusion (Fig. 1). Patients are excluded if pain is
due to intercostal neuralgia of the abdominal wall,
such as abdominal cutaneous nerve entrapment syndrome
(ACNES), or due to lateral femoral cutaneous nerve
entrapment. Other contraindications are listed in Table 1.
Cognitively impaired individuals, patients with ASA class
IV or undergoing secondary or bilateral remedial surgery
are also excluded.
Interventions
The decision to perform a neurectomy and/or mesh re-
moval depends on the surgeon’s subjective interpretation
of patient history, physical examination and intraoperative
findings [17]. All remedial surgeries are performed using
an open approach as previously published [15]. Patients
are randomised to either spinal or general anaesthesia.
Hyperbaric articaine 5% is used for spinal anaesthesia,
considering the relatively short duration of action. Arti-
caine is a amide-type local anaesthetic agent that is prefer-
entially used for short (1 h or less) surgical procedures in
MMC. General anaesthesia is given to the patients follow-
ing standardised procedures.
The administration of other medications during the peri-
operative phase (e.g. ephedrine, atropine and sedatives) is
left to the discretion of the attending anaesthesiologist.
Consequently, the setting of the two types of anaesthesia ra-
ther than the actions of the anaesthetic drugs are investi-
gated. It is allowed for patients who are randomised to the
spinal anaesthesia group to receive midazolam during the
procedure. Midazolam has no effect on perception of pain
so no drug-related sequelae on the primary outcome
measure are expected. If requested, midazolam will be
administered in a dose of 1 mg (if aged over 65 years) or
2 mg (if ASA class below III).
If a patient receives spinal anaesthesia but intrathecal
articaine has insufficient effect, the patient will undergo
surgery under general anaesthesia. Subsequently, this
will be considered as a protocol violation and the par-
ticular patient will be excluded from further analysis.
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Outcomes
Primary outcome is the effect of type of anaesthesia on
pain relief after surgery. Patients are asked to score their
pain using the Numerical Rating Scale (NRS, 0, absent
pain – 10, worst pain imaginable). The first pain score is
obtained in the preoperative phase (t0), Fig. 2. Follow-up
pain levels are determined at five time points to deter-
mine short-term (1 week, 6 weeks and 3 months postop-
eratively, t1–t3) and long-term results (6 months and 12
months postoperatively, t4–t5).
Secondary outcome measures are the effect of type of
anaesthesia on quality of life and patient satisfaction.
Quality of life is measured using the Short Form Health
Survey-12 questionnaire (SF-12). To avoid confusion,
satisfaction is also measured by a NRS-like method,
using an 11-point rating scale.
Other secondary endpoints include differences in pain
medication and both direct and indirect medical costs.
Two different validated questionnaires, developed by the
institute for Medical Technology Assessment (iMTA, Eras-
mus University Rotterdam, www.imta.nl) are used [18].
Complications (both surgery- and anaesthesia-related) are
scored as based on the complication register of the Dutch
Society for Anaesthesiologists. They are classified using the
validated Clavien-Dindo classification [19]. Differences
between various types of remedial surgery and specific
causes of inguinodynia (primary inguinal hernia repair, pri-
mary Pfannenstiel incision, other index surgery, idiopathic
inguinodynia) in relation to efficacy are also determined.
Sample size
SolviMáx was founded in 2011. An increasing num-
ber of patients with potential abdominal wall or
groin pain syndromes are referred to the surgical
specialists (Fig. 3). Approximately 840 unique pa-
tients were analysed in 2014, and 1045 patients in
2015. Approximately 40–45% of these undergo re-
medial surgery.
Sample size was calculated by using a web-based
calculator (www.openepi.com). Results from previous
retrospective studies were used as criteria for eligibil-
ity were similar (Zwaans WA, van Kuijk SM, le Mair
LH, van Kleef M, Scheltinga MR, Roumen RM – un-
published observations). Additional literature regard-
ing anaesthesia on remedial surgery is not available.
Previously demonstrated success rates were 77% in
the spinal anaesthesia group and 58% in the general
anaesthesia group (Zwaans WA, van Kuijk SM, le
Mair LH, van Kleef M, Scheltinga MR, Roumen RM –
unpublished observations). Based on these data, a sample
size of 190 patients is calculated to demonstrate a
potential effect of either type of anaesthesia on pain relief.
This volume of patients is attained after three years
as based on the number of included patients in previ-
ously performed studies (Fig. 4).
Fig. 1 Mesh removal (left) and a neurectomy (right) in patients with inguinodynia following open inguinal hernia repair
Table 1 Contraindications for spinal and general anaesthesia in
the present trial
Relative contraindications Absolute contraindications
Spinal anaesthesia
Deformities of the spinea Refusal by patient
Severe back pain or headache Inadequate coagulation
Pre-existent neurological deficiency
Infection near puncture site
Allergy to local anaesthetic
Inability to communication properly
General anaesthesia
Expected difficulty with airway Refusal by patient
Allergy for (components of) medications
aE.g. arthritis, osteoporosis, metastasis, spinal disc herniation, scoliosis
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Randomisation
Patients will be electronically randomised by the
web-based research software Research Manager (RM,
Cloud 9 Health Solutions©). No blocked randomisation
or prestratification is performed. The decision to execute
a neurectomy and/or mesh removal depends on patient
history, physical examination and intraoperative findings
[17]. Therefore, a prestratified randomisation is not
possible for type of remedial surgery. Consequently,
stratification will be executed within the analysis.
Sequence generation, allocation concealment and
implementation
RM is used to establish an appropriate sequence gener-
ation and allocation concealment. RM generates a
random allocation sequence, after which patients will be
enrolled by the coordinating investigator. By using RM
software, foreknowledge of (upcoming) anaesthesia as-
signments by the investigators is secured. Consequently,
bias due to improper randomisation techniques is
minimised.
Blinding
Blinding of anaesthesiologists, surgeons and patients
is not possible. Since the study is designed to inves-
tigate the setting of type of anaesthesia, where all
factors associated with anaesthesia are of interest,
blinding is not conditional for a robust conclusion
on efficacy of either anaesthetic technique setting.
Fig. 2 Content for the schedule of enrolment, interventions and assessments according to the SPIRIT Statement [16]
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Statistical methods
Data analysis will be performed using SPSS version 22
(SPSS Inc. ©) for Windows. Digital data are easily
exported from RM to SPSS. The primary outcome meas-
ure is pain relief using NRS as compared to the pre-
operative pain levels (t0). Pain reduction is calculated by






Data of the general and spinal anaesthesia group will be
compared using the Student’s t test or the Wilcoxon signed
rank test, as appropriate.
Secondary outcome measures will be compared between
groups at the various postoperative follow-up points. In
Fig. 3 Number of unique patients analysed at SolviMáx Centre of Excellence for Chronic Abdominal Wall and Groin Pain over the years
Fig. 4 Expected inclusion in the present trial, calculated by included patients in previously performed retrospective studies [15]
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addition, outcomes at each evaluation time (t1–t5) will be
compared to preoperative data within groups. The Student’s
t test or the Wilcoxon signed rank test will be used as ap-
propriate. P values ≤ 0.05 are considered statistically signifi-
cant. Intention-to-treat analysis will be applied on the
primary outcome measure.
Recruitment
Patients will be recruited at SolviMáx once the shared de-
cision is taken to perform remedial surgery. During the
subsequent preoperative screening, eligibility of patients
for both general and spinal anaesthesia is assessed. Within
14 days of consideration, informed consent is obtained. If
the patient consents, the coordinating investigator will
randomise the patient as previously described. Patients are
allowed to withdraw at any time point during the study.
Discussion
General anaesthesia is still applied in the majority (60–
70%) of hernia operations [20]. Spinal anaesthesia, on the
other hand, is only performed in 10–20% patients under-
going inguinal hernia surgery [20], although the beneficial
effects regarding postoperative pain were previously dem-
onstrated in primary hernia repair [21, 22]. In addition,
studies on primary inguinal herniorrhaphy showed that
spinal anaesthesia results in shorter hospital stay, less
postoperative analgesic requirements, prolonged time to
first analgesic requirement, equal operation room time
and equal time-to-home readiness [22–24]. Only recently,
a potential beneficial effect of spinal anaesthesia on
surgery for groin pain was demonstrated [15]. This is the
first randomised trial comparing two routine anaesthetic
modalities for remedial surgery. Results of the present trial
may aid in optimising care in these patient populations.
Considering groin pain relief following remedial surgery
for groin pain, spinal anaesthesia is hypothesised to be
superior to general anaesthesia. The assumed beneficial
effect is possibly associated with the spinal block itself
diminishing transmission of nociceptive signals from the
operation site toward the nervous system [21, 25]. How-
ever, as potential confounding factors are not excluded, a
possible beneficial effect cannot be attributed to just one
particular factor. Any potential effect should be consid-
ered as the end result of the total setting of type of anaes-
thesia and associated factors. These confounding factors
include the intrathecal administration of anaesthetics,
articaine or other drugs, patient expectations, surgical
stress, patient’s state (sedated or awake) during surgery,
communication with patients and various other individual
psychological factors. The present study is designed to
generate clinically relevant conclusions that can be dir-
ectly implemented in clinical practice.
In 2004, Burney and coauthors performed a randomised
trial on the effects of anaesthesia in primary herniorrhaphy
[26]. A disappointingly low recruitment rate was observed.
The authors stated that patients had conceptualised
concerns regarding the anaesthetic techniques, and
consequently did not accept a random assignment [26]. It
is theoretically possible that patients who are more anxious
about the upcoming surgical procedure prefer general over
spinal anaesthesia as they do not wish to experience any
‘noise’ from within the operation room. Studies have dem-
onstrated that anxiety is a risk factor for postoperative pain
[27–29]. When these patients are prone to more intense
postoperative pain and thus prefer general anaesthesia,
these issues may have influenced previous outcomes.
In contrast, another study showed that preferred type
of anaesthesia did not contribute to success after
remedial surgery (Zwaans WA, van Kuijk SM, le Mair
LH, van Kleef M, Scheltinga MR, Roumen RM –
unpublished observations). In SolviMáx, a standard
set of intake questionnaires is obtained from all pre-
operative patients including a Pain Catastrophising
Scale (PCS) and a Hospital Anxiety and Depression
Scale (HADS) [30–32]. By analysing these scores in
relation to outcome, it is possible to analyse the influ-
ence of mental status in a later phase.
The majority of studies on chronic postoperative pain
lack sufficient data to draw any robust conclusions. Pre-
viously, authors have claimed that extensive preoperative
data, detailed characteristics of surgical procedures and
measures of acute and chronic postoperative pain (up to
1 year) are essential for a proper evaluation of effects on
pain [29]. The present trial design has included all of
these factors and, therefore, the results can be consid-
ered of sufficient scientific evidence. Furthermore, cost-
effectiveness of both anaesthetic techniques is assessed,
which is critical for clinical practice.
A potential limitation of the present study is its non-
blinded design. Blinding of patients is, in our opinion,
unethical and hardly practicable. Moreover, the main
outcomes of the present trial are subjective. Conse-
quently, these outcomes may be contaminated by recall
bias if patients enrolled in the trial are not blinded to
their treatment allocation [33].
This is the first large randomised controlled trial
comparing two routinely used anaesthetic techniques in
remedial surgery for groin pain. There is a definite need
for evidence-based strategies to optimise the results of
these types of surgery. Besides pain relief, other patient-
related outcome measures are assessed to include pa-
tient’s perspectives on outcome. The first study results
are expected in 2019 and will be communicated via
publication.
Trial status
Period of patient recruitment.
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Additional file
Additional file 1: SPIRIT 2013 Checklist: recommended items to address
in a clinical trial protocol and related documents*. (DOCX 41 kb)
Abbreviations
ACNES: Abdominal cutaneous nerve entrapment syndrome; ASA: American
Society Anesthesiologists; HADS: Hospital Anxiety and Depression Scale;
iMTA: Institute for Medical Technology Assessment; MMC: Máxima Medical
Center; NRS: Numerical Rating Scale; PCS: Pain Catastrophising Scale;





Availability of data and materials
Not applicable.
Authors’ contributions
WZ: conception and design of study, acquisition of data, drafting of
manuscript, critical revision of manuscript. LL: conception and design of
study, drafting of manuscript, critical revision of manuscript. MS: conception
and design of study, acquisition of data, drafting of manuscript, critical
revision of manuscript. RR: conception and design of study, acquisition of
data, drafting of manuscript, critical revision of manuscript. All authors read
and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Not applicable.
Ethics approval and consent to participate
The protocol (protocol number NL54115.015.15) is approved by the Medical
Ethics Committee of Máxima Medical Centre, Veldhoven, the Netherlands.
After recruitment of patients, patients have 14 days of consideration before
informed consent is obtained.
Author details
1Department of General Surgery, Máxima Medical Centre, PO Box 77775500
MB Veldhoven/Eindhoven, The Netherlands. 2SolviMáx, Center of Excellence
for Abdominal Wall and Groin Pain, Máxima Medical Centre, Eindhoven, The
Netherlands. 3Department of Anaesthesiology, Máxima Medical Centre,
Veldhoven, The Netherlands.
Received: 8 July 2016 Accepted: 7 December 2016
References
1. Nienhuijs S, Staal E, Strobbe L, Rosman C, Groenewoud H, Bleichrodt R.
Chronic pain after mesh repair of inguinal hernia: a systematic review. Am J
Surg. 2007;194(3):394–400.
2. Bay-Nielsen M, Perkins FM, Kehlet H. Pain and functional impairment 1 year
after inguinal herniorrhaphy: a nationwide questionnaire study. Ann Surg.
2001;233(1):1–7.
3. Loos MJ, Roumen RM, Scheltinga MR. Classifying post-herniorrhaphy pain
syndromes following elective inguinal hernia repair. World J Surg. 2007;
31(9):1760–5. discussion 1766-7.
4. Loos MJ, Scheltinga MR, Roumen RM. Surgical management of inguinal neuralgia
after a low transverse Pfannenstiel incision. Ann Surg. 2008;248(5):880–5.
5. Licheri S, Pisano G, Erdas E, Ledda S, Casu B, Cherchi MV, Pomata M, Daniele
GM. Endometriosis of the round ligament: description of a clinical case and
review of the literature. Hernia. 2005;9(3):294–7.
6. Hohenfellner R. Nerve injuries in urological surgery. Georgian Med News.
2007;143:7–11.
7. Aasvang EK, Kehlet H. The effect of mesh removal and selective neurectomy
on persistent postherniotomy pain. Ann Surg. 2009;249(2):327–34.
8. Lichtenstein IL, Shulman AG, Amid PK, Montllor MM. Cause and prevention
of postherniorrhaphy neuralgia: a proposed protocol for treatment. Am J Surg.
1988;155(6):786–90.
9. Loos MJ, Verhagen T, Scheltinga MR, Roumen RM. A randomised controlled
trial of injection therapy versus neurectomy for post-herniorrhaphy inguinal
neuralgia: rationale and study design. Hernia. 2010;14(6):593–7.
10. Thomassen I, van Suijlekom JA, van de Gaag A, Ponten JE, Nienhuijs SW.
Ultrasound-guided ilioinguinal/iliohypogastric nerve blocks for chronic pain
after inguinal hernia repair. Hernia. 2013;17(3):329–32.
11. Loos MJ, Scheltinga MR, Roumen RM. Tailored neurectomy for treatment of
postherniorrhaphy inguinal neuralgia. Surgery. 2010;147(2):275–81.
12. Amid PK. A 1-stage surgical treatment for postherniorrhaphy neuropathic pain:
triple neurectomy and proximal end implantation without mobilization of the
cord. Arch Surg. 2002;137(1):100–4.
13. Chen DC, Hiatt JR, Amid PK. Operative management of refractory neuropathic
inguinodynia by a laparoscopic retroperitoneal approach. JAMA Surg. 2013;
148(10):962–7.
14. Bischoff JM, Enghuus C, Werner MU, Kehlet H. Long-term follow-up after mesh
removal and selective neurectomy for persistent inguinal postherniorrhaphy
pain. Hernia. 2013;17(3):339–45.
15. Zwaans WA, Verhagen T, Roumen RM, Scheltinga MR. Factors determining
outcome after surgery for chronic groin pain following a Lichtenstein hernia
repair. World J Surg. 2015;39(11):2652–62.
16. Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gotzsche PC, Krleza-Jeric
K, Hrobjartsson A, Mann H, Dickersin K, Berlin JA, Dore CJ, Parulekar WR,
Summerskill WS, Groves T, Schulz KF, Sox HC, Rockhold FW, Rennie D,
Moher D. SPIRIT 2013 Statement: defining standard protocol items for
clinical trials. Ann Intern Med. 2013;158(3):200–7.
17. Zwaans WA, Perquin CW, Loos MJ, Roumen RM, Scheltinga MR. Mesh
removal and selective neurectomy for persistent groin pain following
Lichtenstein repair. World J Surg. 2016. doi: 10.1007/s00268-016-3780-y.
18. Hakkaart-van Roijen L, Tan SS, Bouwmans CAM. Handleiding voor
kostenonderzoek. Methoden en referentieprijzen voor economische evaluaties
in de gezondheidszorg. Erasmus University Rotterdam commissioned by
College voor Zorgverzekeringen; 2011. Updated 2010.
19. Clavien PA, Sanabria JR, Strasberg SM. Proposed classification of complications of
surgery with examples of utility in cholecystectomy. Surgery. 1992;111(5):518–26.
20. Kehlet H, White PF. Optimizing anesthesia for inguinal herniorrhaphy:
general, regional, or local anesthesia? Anesth Analg. 2001;93(6):1367–9.
21. Tverskoy M, Cozacov C, Ayache M, Bradley Jr EL, Kissin I. Postoperative pain
after inguinal herniorrhaphy with different types of anesthesia. Anesth
Analg. 1990;70(1):29–35.
22. Ozgun H, Kurt MN, Kurt I, Cevikel MH. Comparison of local, spinal, and general
anaesthesia for inguinal herniorrhaphy. Eur J Surg. 2002;168(8–9):455–9.
23. Toivonen J, Permi J, Rosenberg PH. Analgesia and discharge following
preincisional ilioinguinal and iliohypogastric nerve block combined with
general or spinal anaesthesia for inguinal herniorrhaphy. Acta Anaesthesiol
Scand. 2004;48(4):480–5.
24. Song D, Greilich NB, White PF, Watcha MF, Tongier WK. Recovery profiles
and costs of anesthesia for outpatient unilateral inguinal herniorrhaphy.
Anesth Analg. 2000;91(4):876–81.
25. Kitahata LM. Pain pathways and transmission. Yale J Biol Med. 1993;66(5):437–42.
26. Burney RE, Prabhu MA, Greenfield ML, Shanks A, O’Reilly M. Comparison of
spinal vs general anesthesia via laryngeal mask airway in inguinal hernia
repair. Arch Surg. 2004;139(2):183–7.
27. Aasvang E, Kehlet H. Chronic postoperative pain: the case of inguinal
herniorrhaphy. Br J Anaesth. 2005;95(1):69–76.
28. Macrae WA. Chronic pain after surgery. Br J Anaesth. 2001;87(1):88–98.
29. Perkins FM, Kehlet H. Chronic pain as an outcome of surgery. A review of
predictive factors. Anesthesiology. 2000;93(4):1123–33.
30. Sullivan MJL, Bishop S, Pivik J. The pain catastrophizing scale: development
and validation. Psychol Assess. 1995;7:432–524.
31. White D, Leach C, Sims R, Atkinson M, Cottrell D. Validation of the Hospital Anxiety
and Depression Scale for use with adolescents. Br J Psychiatry. 1999;175:452–4.
32. Spinhoven P, Ormel J, Sloekers PP, Kempen GI, Speckens AE, Van Hemert
AM. A validation study of the Hospital Anxiety and Depression Scale (HADS)
in different groups of Dutch subjects. Psychol Med. 1997;27(2):363–70.
33. Hassan E. Recall bias can be a threat to retrospective and prospective
research designs. Int J Epidemiol. 2005;3(2)
Zwaans et al. Trials  (2017) 18:23 Page 7 of 7
